$JBSS

SANFILIPPO JOHN B & SON INC

No enriched coverage for $JBSS in the last 7 days.

No SEC Form 4 filings for $JBSS in the last 30 days.

Med

Trail mix and nuts recalled over potential salmonella contamination

John B. Sanfilippo & Son, Inc. has issued a voluntary recall for various trail mix and nut products, including some sold at Target, due to potential Salmonella contamination from a dry milk powder used as seasoning. Although no Salmonella has been detected in the seasoning and no illnesses have been reported, the recall is a precautionary measure. Consumers are advised to dispose of the products or return them for a refund, and aware of Salmonella symptoms, which can be severe for vulnerable populations.

SANFILIPPO JOHN B&SON ($JBSS) Releases Q3 2026 Earnings

SANFILIPPO JOHN B&SON (JBSS) reported strong Q3 2026 earnings, surpassing analyst estimates for both earnings per share and revenue. The company posted earnings of $1.43 per share against an estimate of $1.18, and revenue reached $281,780,000, exceeding the $266,041,500 estimate. This news follows a period of mixed institutional investor activity and a recent "Buy" rating from BWS Financial.

John B. Sanfilippo & Son (NASDAQ:JBSS) Releases Earnings Results, Beats Estimates By $0.27 EPS

John B. Sanfilippo & Son (NASDAQ:JBSS) announced its quarterly earnings, reporting an EPS of $1.43, exceeding analyst estimates of $1.16 by $0.27. The company's revenue reached $281.78 million, surpassing the consensus of $260.83 million. Additionally, John B. Sanfilippo declared a special dividend of $1.50 per share payable on May 21st, with the stock currently holding a "Hold" rating from analysts and an average price target of $109.00.

News on $JBSS